Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Ingersoll Rand (IR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Ingersoll Rand — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $376.41 (market cap $10.01B), while Ingersoll Rand trades at $71.83 (market cap $27.87B). The key difference: Ingersoll Rand is far larger — about 2.8× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Ingersoll Rand pays a 0.11% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | IR | |
|---|---|---|
Market Cap | $10.01B | $27.87B |
Volume | 324,345 | 8,710,362 |
Sector | Health | Industrials |
52-Week High | $390.34 | $98.76 |
52-Week Low | $241.71 | $68.54 |
Typical Hold Time | 58 Days | — |
Enterprise Value | $9.76B | $31.53B |
Dividend Yield | — | 0.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Rad Laboratories (BIO) trades at $376.41, down 1.57% on the day, with a bullish technical outlook and strong institutional interest. The company reported a return to profitability in 2025 with net income of $759.90 million, though recent quarters show mixed earnings performance. Analyst consensus is bullish with a $350 price target, and positive sentiment is driven by margin improvement targets and participation in investor conferences.
The stock presents a growth opportunity supported by solid fundamentals and bullish analyst ratings, but risks include high valuation multiples and inconsistent earnings beats. Investors should weigh the company's margin expansion goals against potential volatility in life science demand and rich forward earnings estimates.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Ingersoll Rand
Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →
